Page last updated: 2024-10-19

2,3,4,5-tetrahydroxypentanal and Liver Neoplasms

2,3,4,5-tetrahydroxypentanal has been researched along with Liver Neoplasms in 1 studies

Liver Neoplasms: Tumors or cancer of the LIVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wu, XQ1
Fu, JY1
Mei, RY1
Dai, XJ1
Li, JH1
Zhao, XF1
Liu, MQ1

Other Studies

1 other study available for 2,3,4,5-tetrahydroxypentanal and Liver Neoplasms

ArticleYear
Inhibition of Liver Cancer HepG2 Cell Proliferation by Enzymatically Prepared Low-molecular Citrus Pectin.
    Current pharmaceutical biotechnology, 2022, Volume: 23, Issue:6

    Topics: Apoptosis; Cell Proliferation; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Pectins

2022